Presage Biosciences
WA - SeattleBiotechnology
Focus: Presage Biosciences is a newly founded (2024) Seattle-based biotech specializing in targeted tumor drug delivery technology, currently in early-stage development with multiple Phase 1 oncology programs.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Presage Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Presage Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
15 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PRESAE CARE
Frail Elderly SyndromeClinical Trials (1)
NCT06013709A Machine Learning Algorithm to Predict Health Clinical Situations in Primary Healthcare for Frail Older Adults.
N/AHelp build intelligence for Presage Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.